Recombinant Human Hepatocyte nuclear factor 1-alpha (HNF1A)

Code CSB-YP010592HU
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP010592HU
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP010592HU-B
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP010592HU
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP010592HU
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
HNF1A
Uniprot No.
Alternative Names
Albumin proximal factor; Hepatic nuclear factor 1 alpha; Hepatic nuclear factor 1; Hepatic transcription factor 1 alpha; Hepatic transcription factor 1; Hepatocyte nuclear factor 1-alpha; HNF 1; HNF 1A; HNF-1-alpha; HNF-1A; hnf1a; HNF1A_HUMAN; Interferon production regulator factor; LF B1; LF B1 hepatic nuclear factor; LFB 1; LFB1; LFB1 hepatic nuclear factor; Liver specific transcription factor LF B1; Liver specific transcription factor LFB1; Liver-specific transcription factor LF-B1; Maturity onset diabetes of the young 3; MODY 3; MODY3; TCF 1; TCF-1; TCF1; Transcription factor 1; Transcription factor 1 hepatic
Species
Homo sapiens (Human)
Expression Region
1-631
Target Protein Sequence
MVSKLSQLQT ELLAALLESG LSKEALIQAL GEPGPYLLAG EGPLDKGESC GGGRGELAEL PNGLGETRGS EDETDDDGED FTPPILKELE NLSPEEAAHQ KAVVETLLQE DPWRVAKMVK SYLQQHNIPQ REVVDTTGLN QSHLSQHLNK GTPMKTQKRA ALYTWYVRKQ REVAQQFTHA GQGGLIEEPT GDELPTKKGR RNRFKWGPAS QQILFQAYER QKNPSKEERE TLVEECNRAE CIQRGVSPSQ AQGLGSNLVT EVRVYNWFAN RRKEEAFRHK LAMDTYSGPP PGPGPGPALP AHSSPGLPPP ALSPSKVHGV RYGQPATSET AEVPSSSGGP LVTVSTPLHQ VSPTGLEPSH SLLSTEAKLV SAAGGPLPPV STLTALHSLE QTSPGLNQQP QNLIMASLPG VMTIGPGEPA SLGPTFTNTG ASTLVIGLAS TQAQSVPVIN SMGSSLTTLQ PVQFSQPLHP SYQQPLMPPV QSHVTQSPFM ATMAQLQSPH ALYSHKPEVA QYTHTGLLPQ TMLITDTTNL SALASLTPTK QVFTSDTEAS SESGLHTPAS QATTLHVPSQ DPAGIQHLQP AHRLSASPTV SSSSLVLYQS SDSSNGQSHL LPSNHSVIET FISTQMASSS Q
Protein Length
Full length protein
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver. Binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Activates the transcription of CYP1A2, CYP2E1 and CYP3A11.
Gene References into Functions
  1. The results show that individuals with the HNF1A allele might achieve greater benefit with regard to weight loss and improvement of insulin resistance by choosing a hypocaloric and high-fat weight-loss diet than a low-fat diet. PMID: 29424957
  2. These findings show that HNF4A methylation status in the blood of children is associated with metabolic profiles. Therefore, we suggest that the DNA methylation status might serve as a potential epigenetic biomarkers of metabolic syndrome. PMID: 29598821
  3. Lower serum miR-122 is a unique feature of HNF1A-diabetes mellitus patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients. PMID: 30155490
  4. genetic association studies in population of children in Japan: Data suggest that mutations in INS, HNF1A, HNF4A, and HNF1B likely play critical roles in children with insulin-requiring autoantibody-negative type 1 diabetes in the population studied. (INS = insulin; HNF1A = HNF1 homeobox A; HNF4A = hepatocyte nuclear factor 4 alpha; HNF1B = HNF1 homeobox B) PMID: 28597946
  5. Carriers of variant p.E508K in HNF1A have a reduced insulin response rather than the increased sensitivity to sulfonylureas seen in patients with MODY3. PMID: 29844095
  6. no association of rs7305618 or rs2393791 with polycystic ovary syndrome PMID: 29169850
  7. genetic association studies in populations in England and France: Data suggest that SNPs (27L allele) in HNF1A are associated with 1.6-year decrease in age at diagnosis of MODY, specifically in subset of individuals with PTV. (MODY = maturity-onset diabetes of the young; PTV = protein-truncating variant) [META-ANALYSIS] PMID: 29895593
  8. SNPs rs1169288 and rs2464196 of HNF1A gene were significantly associated with metabolic syndrome in a Morrocan population. PMID: 28712822
  9. The prevalence of maturity onset diabetes of the young due to HNF1A variants in Croatia has been determined. PMID: 29666556
  10. Germline HNF1A mutations were identified as the cause of autosomal dominant maturity-onset diabetes of the young type 3 (MODY3), a genetic type 2 diabetes occurring in young patients in a familial context. Liver Adenomatosis associated with MODY3 owing to a germline mutation of HNF1A. PMID: 28733222
  11. HNF1A mutations are associated with MODY 3 phenotype. PMID: 28395978
  12. Genetic variants in HNF1A gene had significantly decreased pancreas weight and insulin mass similar to that of type 1 diabetes. PMID: 28938416
  13. Twenty-five different variants were identified in GCK gene (30 probands-61% of positivity), and 7 variants in HNF1A (10 probands-17% of positivity). Fourteen of them were novel (12- GCK /2- HNF1A ). ACMG guidelines were able to classify a large portion of variants as pathogenic (36%- GCK /86%- HNF1A ) and likely pathogenic (44%- GCK /14%- HNF1A ), with 16% (5/32) as uncertain significance. PMID: 28170077
  14. HNF-1A plays a critical role in lipid and glucose homeostasis in second trimester of pregnancy PMID: 28591938
  15. The HNF1A variant p.Ala180Val does not seem to cause MODY3, although it may confer risk for type 2 diabetes mellitus. PMID: 28934671
  16. the contribution of the Maturity Onset Diabetes of the Young gene HNF1A in the etiology of 23 unrelated Tunisian families PMID: 29408271
  17. genetic association studies in population in Japan: Data suggest that HNF1A diplotype of three genetic risk variants (SNPs rs1169288-C, rs1183910-A, rs2464196-A) may be independent risk factor for development of diabetic retinopathy resulting from poor glycemic control in normal-weight patients with type 2 diabetes in the population studied. PMID: 27445006
  18. data suggested that the missense mutation of HNF1alpha (p.Q511L) may associate with the progression of hepatocellular carcinoma PMID: 29101032
  19. We confirmed that the SNPs in the HNF1A were associated with higher serum ApoA1 levels. Our results indicate that the polymorphic variability in the HNF1A locus may be a factor involving in the risk of CAD and IS. PMID: 28035729
  20. A SNP located in the HNF1A gene is associated with polycystic ovary syndrome (PCOS) among Han Chinese women. This suggested that variations in HNF1A might confer risk for PCOS PMID: 28299548
  21. Lef1 and Tcf1 showed oncogenic effect in colonic carcinogenesis. Cellular context of miRNAs might play important roles in carcinogenesis by altering the expression pattern of Lef/Tcfs members. PMID: 27433921
  22. HNF1alpha, which has previously been described as a modulator of several transporters of the renal transportosome, is also a key determinant of PDZK1 transcription. PMID: 28724612
  23. Results identified HNF1A/B as a good candidates to master the regulation of pancreatic differentiation, which at the protein level loses its expression in malignant ductal cells of the pancreas, suggesting its putative role as tumor suppressor in pancreatic cancer. PMID: 27520560
  24. this study found that 20%-60% of Hepatitis C-specific CD8+ T cells were Tcf1+ PMID: 27533016
  25. Findings suggest that there are subtypes of T2DM characterized by different urinary glucose excretion and cardiovascular risk factors. SLC5A2 and HNF1A mutations partially explain renal glycosuria in patients with T2DM. PMID: 28324025
  26. Results indicate that HNF1alpha can modulate the expression of hepatitis B virus (HBV) large surface proteins to interfere virion production, and HNF1alpha is capable of limiting HBV transcription and replication by activating the NF-kappaB signaling. PMID: 28319127
  27. Study have shown that expression of specific miRNAs depends on HNF1beta function. The impact of HNF1beta deficiency was evidenced at serum level, making HNF1beta-dependent miRNAs potentially applicable in the diagnosis of HNF1B-MODY. PMID: 27059371
  28. Mutation in HNF1A gene is associated with Maturity Onset Diabetes of the Young. PMID: 28095440
  29. CRP increased PCSK9 expression by activating p38MAPK-HNF1alpha pathway, with a certain downstream impairment in LDL metabolism in HepG2 cells. PMID: 27633999
  30. Our data on the first functional study of HNF1A mutations in South India subjects confers that the defect of the HNF-1A mutant proteins are responsible for MODY3 diabetes in these patients PMID: 26853433
  31. 11 variants that reduced HNF-1A transcriptional activity to <60% of normal (wild-type) activity was strongly associated with diabetes in the general population. PMID: 27899486
  32. The G allele of rs7953249 of HNF1A showed nominal association with small vessel disease subtype of ischemic stroke though not survived bonferroni correction for multiple comparisons. PMID: 27460564
  33. Mutation of HNF1A is associated with type 1B diabetes. PMID: 27398945
  34. TCF1 expression is regulated by SOX18 in prostate cancer. PMID: 27922675
  35. HNF1A mutations are associated with Maturity-Onset Diabetes of the Young. PMID: 27634015
  36. HNF1A gene polymorphisms (rs2259816 and rs7310409) showed statistically significant association with risk of coronary artery disease in Iranian patients. PMID: 28222501
  37. We show that SNPs in HNF1A (rs1169288 and rs2464196) are more frequent among dead opioid addicts than living opioid addicts. PMID: 27240623
  38. High TCF-1 expression is associated with dedifferentiated chondrosarcoma. PMID: 27522523
  39. co-expression of HNF4alpha and HNF1alpha is effective for cellular lipid accumulation, while additional factors are probably required for lipoprotein formation and secretion PMID: 27838959
  40. HNF1alpha plays a key role in the constitutive expression of megalin and cubilin, hence regulating endocytosis in the proximal tubule of the kidney. PMID: 27083284
  41. HNF1A mutations are associated with Maturity onset diabetes of youth. PMID: 26669242
  42. Mutations in HNF4A and HNF1A genes might account for this early-onset inherited type 2 diabetes. PMID: 26981542
  43. Letter/Case Report: HNF1A mutation in patient with MODY-3 and familial liver adenomatosis. PMID: 26646800
  44. Hepatocellular adenomas, specifically the HNF1-alpha subtype, can cause false-positive PET findings when seeking to identify malignancy. PMID: 26776850
  45. Plasma ghrelin level is higher in HNF1A-maturity onset diabetes of the young than in the common polygenic forms of diabetes. PMID: 25987348
  46. rejected the hypothesis that all human MODY-associated mutations in HNF1A / HNF4A induce changes in the pharmacokinetics of sulfonylureas in humans analogically to the Hnf1a(-/-) mouse model PMID: 26446475
  47. TCF-1 expression was lower in T cells from multiple sclerosis patients compared to healthy individuals. PMID: 26714756
  48. HNF-1alpha gene p379fsinsC mutation is described in a Chinese family with maturity-onset diabetes of the young type 3. PMID: 26436572
  49. Genetic screening detected a mutation p. Arg200Trp in the HNF1A gene in the patient, her mother, and maternal grandmother, suggesting a diagnosis of MODY-3 PMID: 24014008
  50. DR of any degree was not present in our GCK-MODY group, while in spite of young age almost every fourth subject with HNF1A-MODY showed signs of this complication. PMID: 26240958

Show More

Hide All

Involvement in disease
Hepatic adenomas familial (HEPAF); Maturity-onset diabetes of the young 3 (MODY3); Diabetes mellitus, insulin-dependent, 20 (IDDM20)
Subcellular Location
Nucleus.
Protein Families
HNF1 homeobox family
Tissue Specificity
Liver.
Database Links

HGNC: 11621

OMIM: 142330

KEGG: hsa:6927

STRING: 9606.ENSP00000257555

UniGene: Hs.654455

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X